Non-pharmaceutical treatment combats recurring Clostridium Difficile infections
Transplanting human donor fecal microbiota into the colon of a patient infected with Clostridiodes difficile (C. diff) may be the best treatment for those not helped by C. diff targeted antibiotics, according to an article in the Journal of the American Osteopathic Association.
C. diff is the most common healthcare-acquired infection in the United States. It affects nearly half a million patients each year and becomes a recurring infection for nearly a third of them. If untreated, C. diff can lead to sepsis and death.
“Twenty five years ago C. diff infections were easier to manage and often resolved with discontinuation of the initiating antibiotic,” says Robert Orenstein, DO, an infectious disease specialist at Mayo Clinic and lead author on this article. “However, these infections have become increasingly common and pernicious.”
The standard and FDA-approved treatment for C. diff is a course of oral vancomycin, an antibiotic. However, even the medications used to eliminate C. diff can perpetuate the infection by killing off beneficial microbes. Newer antibiotics that more specifically target C. diff have been developed but they can be prohibitively expensive, according to Dr. Orenstein.
“Think of your gut as a forest and C. diff as a weed,” says Dr. Orenstein. “In a thriving forest, weeds barely get a foothold. But if you burn the forest down, the weeds are going to flourish.”
Unlike antibiotics, which are destructive by definition, fecal transplants or microbial replacement therapies, repopulate the gut with a diverse group of microbes that may block the C. diff‘s spore from germinating and propagating disease via its toxins. Transplants have several delivery methods, including enemas, capsules and direct instillation, to replace the diverse flora that maintain health and improve metabolism.
Currently, there are no FDA-approved fecal transplant products and performing fecal transplants is considered an investigational procedure. Dr. Orenstein notes there are several companies with products in Phase 3 clinical trials that could come to market as early as 2020. For this reason he strongly urges healthcare providers to refer patients with recurrent C. diff for these trials rather than for fecal transplants. In the meantime, the FDA reserves fecal transplants for patients who have experienced a second recurrence (third episode) of C. diff infection.
C. diff is common in healthcare settings and public spaces and rarely causes problems in people with healthy gut microbiota and immune systems, according to researchers. However, people who are already ill and taking antibiotics, chemotherapy, or proton pump inhibitors–which all greatly disrupt the gut ecosystem–are at risk. Elderly patients are especially vulnerable.
Dr. Orenstein expects the new treatment options will improve outcomes but says physicians need to assume greater responsibility for prevention.
“One of the most effective things physicians can do is become more responsible with antibiotic prescriptions,” says Dr. Orenstein. “That means only prescribing when they are clearly indicated, not for colds or viral sinus infections. We also must be especially judicious with elderly patients.”
The Latest on: Fecal transplants
via Google News
The Latest on: Fecal transplants
- Here’s why you should always close the toilet lid before you flushon November 3, 2020 at 8:03 am
All that bubbling, swirling and splashing can aerosolize fecal waste, sending tiny particles ... caregivers in the hands of organ donors and transplant doctors in Chicago. WASHINGTON (NewsNation ...
- Poop transplant death linked to E. colion October 30, 2020 at 4:59 pm
Earlier this year, the US Food and Drug Administration issued a warning regarding the safety of so-called fecal microbiota transplants (FMTs). The bulletin came after two patients were infected ...
- Doctors report first death from fecal microbiota transplanton October 30, 2020 at 4:59 pm
This spring, the Food and Drug Administration (FDA) announced that a 73-year-old man had died and another person had become sick after receiving fecal microbiota transplants (FMTs). The donor ...
- Discoveries reshape understanding of gut microbiomeon October 22, 2020 at 11:07 am
And when mice without this protective barrier received a transplant of fecal matter with microbiome, their mucus production jump-started. This may have significant treatment implications for ...
- These scientists say that feeding C-section babies a bit of their mom’s poop can improve their gut healthon October 21, 2020 at 6:06 am
Fecal microbiota transplants have been used in medicine to treat things such as C. difficile infections and ulcerative colitis since the late 1900s. Nature actually wants newborns to come in conta ...
- A Stool Bank in Massachusetts Will Pay You $40 a Day for Your Pooon October 20, 2020 at 5:00 pm
The stool samples will be used for fecal transplants, to fight the deadly superbug C. difficile, which affects more than 500,000 and kills 14,000 Americans per year. If you’re wondering about ...
- Autism’s Gut Connection: Microbes Could Soon Lead to New Treatmentson October 13, 2020 at 8:22 pm
Researchers are finding clues to autistic behavior — in patients’ gut bacteria. Using fecal transplants to improve symptoms have shown promise in preliminary studies. By Adam Piore October 13, 2020 ...
- Microbiome Therapeutics: Global Marketson October 13, 2020 at 7:07 am
utm_source=GNW The report analyzes the market by segmenting it into the various types of microbiome therapeutics, based on the strategies used for treatment: additive (fecal matter transplants or FMTs ...
- Alteration of the Intestinal Microbiomeon October 12, 2020 at 5:00 pm
The role of the microbiome in the pathophysiology of and treatment of other diseases requires much further research and well-designed controlled trials before any manipulation of the fecal ...
- Should the FDA regulate fecal transplants as if poop is a drug or a bodily tissue?on October 5, 2020 at 5:00 pm
That’s a question the FDA has to answer in order to regulate fecal microbiota transplants (FMT), a treatment in which feces is transferred from a healthy donor to one suffering from ...
via Bing News